An Extension Study to Investigate the Safety and Durability of Clinical Activity of CAL-101 in Patients with Hematologic Malignancies

Type of Cancer
Hematological Malignancies

Site
Bethesda

Protocol Number
CAL101-99

To Learn More Call
201-510-0910